• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Simply Solventless To Acquire CannMart As It Seeks To Expand Into Hydrocarbon Cannabis Concentrates

    6/26/24 8:58:06 AM ET
    $LFST
    Medical/Nursing Services
    Health Care
    Get the next $LFST alert in real time by email

    Simply Solventless Concentrates Ltd. (TSXV:HASH) is acquiring Lifeist Wellness Inc.'s (TSXV:LFST) (FRANKFURT: M5B) (OTC:LFSWF) subsidiary CannMart Inc.

    What Happened

    The Calgary, Alberta-based company said on Wednesday that it has entered into a services agreement regarding the operations of CannMart and a share purchase agreement with Lifeist Wellness Inc. to acquire all of the shares of CannMart.

    See also: Canadian Company Lifeist Says Farewell To Cannabis Business Unit, Turns To Nutraceuticals

    Key terms of the services agreement are as follows: 

    • SCC will receive the benefit of 100% of CannMart’s revenue, less a service fee of 10% of net revenue;
    • SSC will help to manage the day-to-day operations of CannMart;
    • SSC will pay 100% of CannMart’s operating expenses;
    • All service fee payments paid by SSC to CannMart during the term of the services agreement will be deducted from the purchase price in respect of the acquisition of CannMart;
    • SSC will receive the benefit of a further purchase price adjustment to reflect $500,000 of CannMart inventory at the effective date of the services agreement; and
    • The services agreement will terminate upon the closing of the acquisition of CannMart.

    The purchase price under the agreement includes $500,000 cash, $500,000in units on the same terms as the financing, and a vendor takeback note of $1,500,000 on the closing of the acquisition.

    SSC noted in a press release the agreements related to both transactions are dated June 25, 2024. CannMart Labs Inc., another of Lifeist’s subsidiaries, which is currently in the companies’ creditors arrangement act (Canada) proceedings, is not involved in the transactions.

    To learn more about exciting partnership in cannabis, come, join us at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.

    Private Placement of Units

    SSC simultaneously announced a non-brokered private placement of up to 14 million units at $0.25 per unit for aggregate gross proceeds of up to $3.5 million, with each unit consisting of one common share and one-half of one common share purchase warrant of SSC. Each whole warrant is exercisable for one common share of SSC at $0.40 per share for two years from the date of issue. The financing, which is subject to the approval of the TSXV is expected to close on or around July 5, 2024.

    Board And Management Changes

    Jeff Lawrence, SSC’s vice president of sales and marketing, has been promoted to the position of chief commercial officer. 

    Colin Davison, a member of SSC’s board of directors, and Randeep Gill, SSC’s vice president of commercials, have resigned due to personal reasons.

    Why It Matters

    CannMart owns the brands Roilty and Zest Cannabis both featuring hydrocarbon extract products in Alberta, Ontario, Saskatchewan and Manitoba as well as a presence in Quebec, the Maritimes, and the Territories.

    “Through CannMart, Lifeist has done a fantastic job of building two great brands, Roilty and Zest Cannabis, and achieving national reach and substantial revenue capability," Jeff Swainson, SSC’s president & CEO, said. "Continuing SSC’s strategic objective of opportunistic acquisitions, these Transactions establish SSC as one of the leaders in hydrocarbon concentrates, taking the baton from Lifeist, and building strongly upon SSC’s leadership position in solventless concentrates."

    CannMart also has a Health Canada-licensed facility in Ontario near the Ontario Cannabis Store warehouse.

    What's Next

    "Moving forward, the focus of our talented team will be the integration of CannMart, continued profitable organic branded revenue growth and opportunistic acquisitions such that we provide continued value to our shareholders," Swainson said.

    Closing of the acquisition is subject to a number of conditions precedent, including but not limited to the approval of the TSXV, notification which is satisfactory to Health Canada and approval of the shareholders of Lifeist.

    Get the next $LFST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LFST

    DatePrice TargetRatingAnalyst
    12/9/2025$8.00Overweight
    Barclays
    11/13/2025$8.00Outperform
    BMO Capital Markets
    7/25/2025$8.00Buy
    BTIG Research
    5/27/2025$8.50Neutral → Buy
    UBS
    4/8/2025$9.00Overweight
    KeyBanc Capital Markets
    4/3/2025$8.00Buy
    Canaccord Genuity
    12/16/2024$10.00Neutral → Buy
    Goldman
    1/3/2024$7.00Underweight
    Barclays
    More analyst ratings

    $LFST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on LifeStance Health Group with a new price target

    Barclays initiated coverage of LifeStance Health Group with a rating of Overweight and set a new price target of $8.00

    12/9/25 8:50:31 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    BMO Capital Markets initiated coverage on LifeStance Health Group with a new price target

    BMO Capital Markets initiated coverage of LifeStance Health Group with a rating of Outperform and set a new price target of $8.00

    11/13/25 9:14:47 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    BTIG Research initiated coverage on LifeStance Health Group with a new price target

    BTIG Research initiated coverage of LifeStance Health Group with a rating of Buy and set a new price target of $8.00

    7/25/25 9:06:51 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by LifeStance Health Group Inc.

    4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

    3/11/26 7:03:37 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Director Burdick Kenneth A covered exercise/tax liability with 327,209 shares and was granted 740,504 shares, increasing direct ownership by 14% to 3,425,315 units (SEC Form 4)

    4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

    3/11/26 7:07:25 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by LifeStance Health Group Inc.

    4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

    3/11/26 6:59:06 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Burdick Kenneth A bought $498,294 worth of shares (114,181 units at $4.36), increasing direct ownership by 2% to 3,436,571 units (SEC Form 4)

    4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

    8/12/25 4:30:22 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    LifeStance Health Group Announces Launch of Secondary Public Offering

    SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the "SEC"), certain stockholders of the Company (the "Selling Stockholders") intend to offer 25,000,000 shares of LifeStance's common stock, par value $0.01 per share (the "Common Stock"). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive an

    2/25/26 4:48:44 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026

    SCOTTSDALE, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2025 earnings release before the market opens on Wednesday, February 25, 2026. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 25, 2026, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 3993891, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentat

    2/9/26 4:10:00 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Nearly 7 in 10 Americans Feel Pressure to Appear Happier Than They Are This Holiday Season

    LifeStance Survey Reveals How the Holidays Affect Mental Health, with Stress and Social Pressure Hitting Millennials and Gen Z Hardest SCOTTSDALE, Ariz., Nov. 5, 2025 /PRNewswire/ -- Findings from a LifeStance Health survey released today reveal that for many Americans, the holiday season involves a complex mix of emotions, including reported feelings of stress and pressure. These trends are particularly pronounced among younger generations. The survey explored topics commonly addressed in therapy around the holidays, including seasonal stress, navigating social gatherings, pe

    11/5/25 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    SEC Filings

    View All

    SEC Form 8-K filed by LifeStance Health Group Inc.

    8-K - LifeStance Health Group, Inc. (0001845257) (Filer)

    3/11/26 5:16:58 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    SEC Form 8-K filed by LifeStance Health Group Inc.

    8-K - LifeStance Health Group, Inc. (0001845257) (Filer)

    3/2/26 4:30:15 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    SEC Form 424B7 filed by LifeStance Health Group Inc.

    424B7 - LifeStance Health Group, Inc. (0001845257) (Filer)

    2/27/26 7:00:54 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    Leadership Updates

    Live Leadership Updates

    View All

    Sarah Personette Appointed to LifeStance Board of Directors

    Director William Miller to Step Down SCOTTSDALE, Ariz., Aug. 22, 2025 /PRNewswire/ -- LifeStance Health (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced the appointment of Sarah Personette, an accomplished customer experience, media and technology executive, to the company's board of directors, effective today. William Miller, Wellsky Chairman and CEO, will step down from the board after five years of service. "Sarah's longstanding focus on understanding consumer behavior to improve the customer experience parallels our com

    8/22/25 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    LifeStance Names Vaughn Paunovich as Chief Technology Officer

    SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance's end-to-end technology strategy, ensuring that the organization continues to deliver a best-in-class technology experience for its patients and clinicians. "Vaughn brings a demonstrated track record of leading high-performing technology teams and delivering digital exp

    5/14/25 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

    Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

    5/7/25 2:00:00 PM ET
    $CNC
    $LFST
    Medical Specialities
    Health Care
    Medical/Nursing Services

    $LFST
    Financials

    Live finance-specific insights

    View All

    LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026

    SCOTTSDALE, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2025 earnings release before the market opens on Wednesday, February 25, 2026. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 25, 2026, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 3993891, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentat

    2/9/26 4:10:00 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025

    SCOTTSDALE, Ariz., Oct. 16, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter 2025 earnings release before the market opens on Thursday, November 6, 2025. LifeStance will host a live earnings conference call to discuss third quarter results on November 6, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 3958273, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance In

    10/16/25 4:10:00 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    LifeStance to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025

    SCOTTSDALE, Ariz., July 17, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2025 earnings release before the market opens on Thursday, August 7, 2025. LifeStance will host a live earnings conference call to discuss second quarter results on August 7, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 1294873, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Inve

    7/17/25 4:10:00 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    $LFST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

    SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/14/24 4:34:15 PM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

    SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/14/24 9:59:56 AM ET
    $LFST
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

    SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

    11/8/24 4:33:25 PM ET
    $LFST
    Medical/Nursing Services
    Health Care